The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Cancer incidence and mortality in China, 2016
Open accessAbstract
Background: National Cancer Center (NCC) of China annually reports the nationwide statistics for cancer incidence and mortality using population-based cancer registry data from all available cancer registries in China. Methods: There were a total of 487 registries which reported high quality data of cancer incidence and mortality across China in 2016. The nationwide numbers of new cancer cases and deaths were estimated using the pooled cancer registry data, which were stratified by area (urban/rural), sex, age group (0, 1-4, 5-9, 10-14…85+) and cancer site for incidence and mortality, and then multiplied by corresponding national population. The world Segi's population was applied for the calculation of age-standardized rates. Results: About 4,064,000 new cancer cases and 2,413,500 new cancer deaths occurred in China in 2016. Cancers of the lung, colon-rectum, stomach, liver and female breast were the top five common cancers, accounting for 57.4% of total cancer new cases. Cancers of the lung, liver, stomach, colon-rectum and esophagus were the five leading causes of cancer deaths, accounting for 69.3% of total cancer deaths. The crude and age-standardized incidence rates (ASIR) were 293.91 and 186.46 per 100,000 population, respectively. The crude mortality rate was 174.55/100,000 and the age-standardized mortality rate (ASMR) was 105.19/100,000. The ASIR was higher but the ASMR was lower in urban areas than that in rural areas. In past decades, the ASIR was relatively stable in males, but significantly increased by about 2.3% per year in females for overall cancers combined. In contrast, the ASMR significantly decreased by about 1.2% per year for both sexes during 2000-2016. Notably, the cancer-specific ASIR and ASMR of esophageal, stomach, and liver cancers decreased significantly, whereas both rates for cancers of the colon-rectum, prostate, female breast, cervix, and thyroid increased significantly. Conclusions: Cancer remains a major public health problem in China, which demands long-term collaborative efforts of a broad community. With the national guideline on cancer prevention and control, tailored cancer prevention and control programs are needed in different regions to help reduce the burden of these highly fatal diseases in China.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038 · cited 1×
“More details about those registries have been reported in a previous study 1 .”
Self-citationSiegel, R. L., Giaquinto, A. N., & Jemal, A. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21820 · Cited by 9,533
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Self-citationCancer incidence and mortality in China, 2014
Chen, W., National Office for Cancer Prevention and Control, N. C. C. H., Sun, K., Zheng, R., Zeng, H., Zhang, S., Xia, C., Yang, Z., Li, H., Zou, X., et al. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.01.01 · Cited by 1,007
Self-citationGlobal burden of hepatitis B virus: current status, missed opportunities and a call for action
Hsu, Y.-C., Huang, D. Q., & Nguyen, M. H. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00760-9 · Cited by 632
Bray, F., & Parkin, D. M. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.032 · Cited by 628
Wang, L., Zhou, B., Zhao, Z., Yang, L., Zhang, M., Jiang, Y., Li, Y., Zhou, M., Wang, L., Huang, Z., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00798-4 · Cited by 585
Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness
Parkin, D. M., & Bray, F. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.033 · Cited by 536
Cancer registration in China and its role in cancer prevention and control
Wei, W., Zeng, H., Zheng, R., Zhang, S., An, L., Chen, R., Wang, S., Sun, K., Matsuda, T., Bray, F., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30073-5 · Cited by 497
Self-citationCancer deaths and cases attributable to lifestyle factors and infections in China, 2013
Islami, F., Chen, W., Yu, X. Q., Lortet-Tieulent, J., Zheng, R., Flanders, W. D., Xia, C., Thun, M. J., Gapstur, S. M., Ezzati, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx342 · Cited by 438
Self-citationCancer incidence and mortality in China, 2015
Zhang, S., Sun, K., Zheng, R., Zeng, H., Wang, S., Chen, R., Wei, W., & He, J. (2021) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2020.12.001 · Cited by 389
Self-citationLiver cancer incidence and mortality in China: Temporal trends and projections to 2030
Zheng, R., Office for Cancer Registry, N. C. C. C. R. C. F. C. H., Qu, C., Zhang, S., Zeng, H., Sun, K., Gu, X., Xia, C., Yang, Z., Li, H., et al. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.06.01 · Cited by 343
Self-citationWei, W.-Q., Chen, Z.-F., He, Y.-T., Feng, H., Hou, J., Lin, D.-M., Li, X.-Q., Guo, C.-L., Li, S.-S., Wang, G.-Q., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.0423 · Cited by 329
Self-citationChen, W., Xia, C., Zheng, R., Zhou, M., Lin, C., Zeng, H., Zhang, S., Wang, L., Yang, Z., Sun, K., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30488-1 · Cited by 288
Self-citationChen, R., Liu, Y., Song, G., Li, B., Zhao, D., Hua, Z., Wang, X., Li, J., Hao, C., Zhang, L., et al. (2021) · Gut · doi:10.1136/gutjnl-2019-320200 · Cited by 222
Self-citationZeng, H., Ran, X., An, L., Zheng, R., Zhang, S., Ji, J. S., Zhang, Y., Chen, W., Wei, W., & He, J. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00157-2 · Cited by 221
Self-citationTobacco smoking in China: Prevalence, disease burden, challenges and future strategies
ZHANG, J., OU, J., & BAI, C. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02062.x · Cited by 186
Attributable causes of cancer in China
Wang, J., Jiang, Y., Liang, H., Li, P., Xiao, H., Ji, J., Xiang, W., Shi, J. F., Fan, Y. G., Li, L., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds139 · Cited by 127
Self-citationMapping overdiagnosis of thyroid cancer in China
Li, M., Zheng, R., Maso, L. D., Zhang, S., Wei, W., & Vaccarella, S. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00083-8 · Cited by 89
Self-citationProvincial-level cancer burden attributable to active and second-hand smoking in China
Xia, C., Zheng, R., Zeng, H., Zhou, M., Wang, L., Zhang, S., Zou, X., Sun, K., Yang, Z., Li, H., et al. (2018) · Tobacco Control · doi:10.1136/tobaccocontrol-2018-054583 · Cited by 58
Self-citationAttributable causes of lung cancer incidence and mortality in China
Wang, J., Fan, Y., Jiang, Y. L., Li, P., Xiao, H., Chen, W., Wei, W., Zhou, Q., Qiao, Y., & Boffetta, P. (2011) · Thoracic Cancer · doi:10.1111/j.1759-7714.2011.00067.x · Cited by 41
Self-citationTobacco‐attributable burden of cancer according to socioeconomic position in France
Menvielle, G., Kulhánová, I., Bryère, J., Launoy, G. D., Eilstein, D., Delpierre, C., & Soerjomataram, I. (2018) · International Journal of Cancer · doi:10.1002/ijc.31328 · Cited by 25
Cited by
Cancer incidence and mortality in China, 2022
Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.01.006 · Cited by 2,243
Self-citationRegulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng, F., Liao, M., Qin, R., Zhu, S., Peng, C., Fu, L., Chen, Y., & Han, B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01110-y · Cited by 832
Qi, J., Li, M., Wang, L., Hu, Y., Liu, W., Long, Z., Zhou, Z., Yin, P., & Zhou, M. (2023) · The Lancet Public Health · doi:10.1016/s2468-2667(23)00211-6 · Cited by 530
Updates on global epidemiology, risk and prognostic factors of gastric cancer
Yang, W.-J., Zhao, H.-P., Yu, Y., Wang, J.-H., Guo, L., Liu, J.-Y., Pu, J., & Lv, J. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i16.2452 · Cited by 513
Breast cancer: an up‐to‐date review and future perspectives
Hong, R., & Xu, B. (2022) · Cancer Communications · doi:10.1002/cac2.12358 · Cited by 407
Metadata
- Authors
- Zheng, R., Zhang, S., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J.
- Venue
- Journal of the National Cancer Center
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 2
- Issue
- 1
- Pages
- 1-9
- ISSN
- 2096-8663 (ISSN-L)
- 2667-0054
- OpenAlex
- W4214669832
- Cited by
- 1,494
- References
- 25
- FWCI
- 127.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.